Ignacio Atal

发表

Association between trial registration and treatment effect estimates: a meta-epidemiological study

Isabelle Boutron, Philippe Ravaud, Ignacio Atal, 2016, BMC Medicine.

Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform

C. Gabay, X. Puéchal, Ignacio Atal, 2020, Orphanet Journal of Rare Diseases.

Ten Years of Interventional Research in Systemic Sclerosis: A Systematic Mapping of Trial Registries

P. Ravaud, Ignacio Atal, Aïda Bafeta, 2019, Arthritis care & research.

A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non-high-income regions.

Philippe Ravaud, Raphaël Porcher, Ludovic Trinquart, 2018, Journal of clinical epidemiology.

Reporting quality of studies using machine learning models for medical diagnosis: a systematic review

Philip Smith, P. Ravaud, J. Selfe, 2020, BMJ Open.

Avoidable waste of research related to outcome planning and reporting in clinical trials

I. Boutron, P. Ravaud, A. Dechartres, 2018, BMC Medicine.

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study

David Moher, Douglas G Altman, Isabelle Boutron, 2017, British Medical Journal.

Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials

P. Ravaud, A. Dechartres, C. Riveros, 2016, BMC Medicine.

The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses.

Isabelle Boutron, Philippe Ravaud, Raphaël Porcher, 2019, Journal of clinical epidemiology.

Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries

Aurélie Névéol, Philippe Ravaud, Raphaël Porcher, 2016, BMC Bioinformatics.

Automatic screening using word embeddings achieved high sensitivity and workload reduction for updating living network meta-analyses.

Philippe Ravaud, Ivan Lerner, Ignacio Atal, 2019, Journal of clinical epidemiology.

Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials

Philippe Ravaud, Raphaël Porcher, Ludovic Trinquart, 2015, PloS one.

Post‐marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross‐sectional study

G. Baron, P. Ravaud, J. Ross, 2018, International journal of cancer.

Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries

L. Trinquart, R. Porcher, P. Ravaud, 2016, BMC Bioinformatics.

Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis

G. Baron, P. Ravaud, Nicholas Downing, 2018, Clinical pharmacology and therapeutics.

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study

G. Baron, P. Ravaud, J. Ross, 2017, BMJ Open.

Association Between Publication Characteristics and Treatment Effect Estimates

Philippe Ravaud, Joerg Meerpohl, Ignacio Atal, 2018, Annals of Internal Medicine.

External factors may influence Cochrane reviewers when classifying the risk of bias of original reports.

P. Bossuyt, P. Ravaud, A. Dechartres, 2020, Journal of clinical epidemiology.

Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design

P. Bossuyt, P. Ravaud, A. Dechartres, 2019, BMJ Open.